Amygdalar opioids modulate hypothalamic melanocortin-induced anorexia

Physiology and Behavior

Volumn 96, Issue 4-5, 2009, Pages 568-573

  Beckman, Tiffany R ^a   Shi, Qiuying ^b   Levine, Allen S ^b,c   Billington, Charles J ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b University of Minnesota   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Amygdala; Brain; Food intake; Hypothalamus; Limbic; Melanocortins; Opioids; Reward

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MELANOCORTIN; MELANOTAN II; MU OPIATE RECEPTOR AGONIST; NALTREXONE; OPIATE; OPIATE ANTAGONIST;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANOREXIA; APPETITE; ARTICLE; BRAIN; CONTROLLED STUDY; EATING DISORDER; FEEDING BEHAVIOR; FOOD DEPRIVATION; FOOD INTAKE; HYPOTHALAMUS; LIMBIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; SPRAGUE DAWLEY RAT;

ALPHA-MSH; AMYGDALA; ANALGESICS, OPIOID; ANIMALS; APPETITE REGULATION; DRUG INTERACTIONS; EATING; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; FOOD DEPRIVATION; HORMONES; MALE; MELANOCORTINS; NALTREXONE; NEURAL PATHWAYS; NEUROTRANSMITTER AGENTS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, OPIOID, MU;

EID: 60249093990     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2008.12.007     Document Type: Article

References (59)

1. Giraudo S.Q., Billington C.J., and Levine A.S. Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the central nucleus of the amygdala and in the paraventricular nucleus in the rat. Brain Res 782 (1998) 18-23
2. Giraudo S.Q., Billington C.J., and Levine A.S. Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands. Brain Res 809 (1998) 302-306
3. Giraudo S.Q., Kotz C.M., Billington C.J., and Levine A.S. Association between the amygdala and nucleus of the solitary tract in m-opioid induced feeding in the rat. Brain Res 802 (1998) 184-188
4. Glass M.J., Billington C.J., and Levine A.S. Naltrexone administered to central nucleus of amygdala or PVN: neural dissociation of diet and energy. Am J Physiol Regul Integ Comp Physiol 279 (2000) R86-R92
5. Hansen M.J., and Morris M.J. Evidence for an interaction between neuropeptide Y and the melanocortin-4 receptor on feeding in the rat. Neuropharmacology 42 (2002) 792-797
6. Hansen M.J., Schioth H.B., and Morris M.J. Feeding response to a melanocortin agonist and antagonist in obesity induced by a palatable high-fat diet. Brain Res 1039 (2005) 137-145
7. Pomonis J.D., Levine A.S., and Billington C.J. Interaction of the hypothalamic paraventricular nucleus and central nucleus of the amygdala in naloxone blockade of neuropeptide Y-induced feeding revealed by c-fos Expression. J Neurosci 17 13 (1997) 5175-5182
8. Raposinho P.D., White R.B., and Aubert M.L. The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y but does not affect NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat. J Neuroendocrinol 15 (2003) 173-181
9. Wirth M.M., Olszewski P.K., Yu C., Levine A.S., and Giraudo S.Q. Paraventricular hypothalamic a-melanocyte-stimulating hormone and MTII reduce feeding without causing aversive effects. Peptides 22 (2001) 129-134
10. Billington C.J., Briggs J.E., Harker S., Grace M.K., and Levine A.S. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol Regul Integ Comp Physiol 266 (1994) R1765-R1770
11. Levine A.S., and Billington C.J. Peptides in regulation of energy metabolism and body weight. Regulation of body weight: biological and behavioral mechanisms (1996), Wiley, New York
12. Aggleton J.P., and Mishkin M. The amygdala: sensory gateway to the emotions. Emotion: theory, research, experience (1986), Academic, London
13. MacDonald A.F., Billington C.J., and Levine A.S. Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat. Am J Physiol Regul Integ Comp Physiol 285 (2003) 999-1004
14. MacDonald A.F., Billington C.J., and Levine A.S. Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens. Brain Res 1018 (2004) 78-85
15. Benoit S., Schwartz M., Baskin D., Woods S., and Seeley R. CNS melanocortin system involvement in the regulation of food intake. Hormones and Behavior 37 (2000) 299-305
16. Pritchard L.E., Turnbull A.V., and White A. Pro-opiomelancortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol 172 (2005) 411-421
17. Rafflin-Sanson M.L., Keyzer Y.d., and Bertagna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol 149 (2003) 79-90
18. Ramos E.J.B., Meguid M.M., Campos A.C.L., and Coelho J.C.U. Neuropeptide Y, a-melanocyte-stimulating hormone, and monoamines in food intake regulation. Nutrition 21 (2005) 269-279
19. Wardlaw S.L. Obesity as a neuroendocrine disease: lessons to be learned from proopiomelancortin and melanocortin receptor mutations in mice and men. J Clin Endocrinol Metab 86 4 (2001) 1442-1446
20. Yang Y.K., and Harmon C.M. Recent developments in our understanding of melanocortin system in the regulation of food intake. Obes Rev 4 (2003) 239-248
21. Benoit S.C., Clegg D.J., Barrera J.G., Seeley R.J., and Woods S.C. Learned meal initiation attenuates the anorexic effects of the melanocortin agonist MTII. Diabetes 52 (2003) 2684-2688
22. McMinn J.E., Wilkinson C.W., Havel P.J., Woods S.C., and Schwartz M.W. Effect of intracerebroventricular a-MSH on food intake, adiposity, and c-Fos induction, and neuropeptide expression. Am J Physiol Regul Integ Comp Physiol 279 (2000) R695-R703
23. Biebermann H., Krude H., Elsner A., Chubanov V., Gudermann T., and Gruters A. Autosomal dominant mode of inheritance of a melancortin-4 receptor mutation in a patient with severe early onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 52 (2003) 2984-2988
24. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., et al. Targeted disruption of the melancortin-4 receptor results in obesity in mice. Cell 88 (1997) 131-141
25. Krude H., Beibermann H., Luck W., Horn R., Brabant G., and Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet (1998) 155-157
26. Kim E.M., Grace M.K., O'Hare E., Billington C.J., and Levine A.S. Injection of a-MSH, but not B-endorphin, into the PVN decreases POMC gene expression in the ARC. NeuroReport 13 (2002) 497-500
27. Cota D., Tschop M.H., Horvath T.L., and Levine A.S. Cannabinoids, opioids and eating behavior: the molecular face of hedonism?. Brain Res Rev 51 (2006) 85-107
28. Levine A.S. The animal model in food intake regulation: examples from the opioid literature. Physiol Behav 89 (2006) 92-96
29. Levine A.S., and Billington C.J. Opioids as agents of reward-related feeding: a consideration of the evidence. Physiol Behav 82 (2004) 57-61
30. Yeomans M.R., and Gray R.W. Selective effects of naltrexone on food pleasantness and intake. Physiol Behav 60 2 (1995) 439-446
31. Yeomans M.R., and Gray R.W. Opioid peptides and the control of human ingestive behavior. Neurosci Biochem Rev 26 (2002) 713-728
32. Cooper S.J., and Turkish S. Effects of naltrexone on food preference and concurrent behavioral responses in food-deprived rats. Pharmacol Biochem Behav 33 (1989) 17-20
33. Glass M.J., Grace M.K., Cleary J.P., Billington C.J., and Levine A.S. Naloxone's effect on meal microstructure of sucrose and cornstarch diets. Am J Physiol Regul Integ Comp Physiol 281 (2001) R1605-R1612
34. Olszewski P.K., and Levine A.S. Central opioids and consumption of sweet tastants: when reward outweighs homeostasis. Physiol Behav 91 5 (2007) 506-512
35. Colantuoni C., Schwenker J., McCarthy J., Rada P., Ladenheim B., Cadet J.L., et al. Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport 12 16 (2001) 3549-3552
36. Glass M.J., Grace M.K., Cleary J.P., Billington C.J., and Levine A.S. Potency of naloxone's anorectic effect in rats is dependent on diet preference. Am J Physiol Regul Integ Comp Physiol 271 1 pt 2 (1996) R217-R221
37. Levine A.S., Weldon D.T., Grace M.K., Cleary J.P., and Billington C.J. Naloxone blocks that portion of feeding driven by sweet taste in food-restricted rats. Am J Physiol Regul Integ Comp Physiol (1994) R248-R252
38. Bodnar R.J., Glass M.J., Ragnauth A., and Cooper M.L. General, m and k opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions. Brain Res 700 (1995) 205-212
39. Kotz C.M., GLass M.J., Levine A.S., and Billington C.J. Regional effect of naltrexone in the nucleus of the solitary tract in blockade of NPY-induced feeding. Am J Physiol Regul Integ Comp Physiol 278 (2000) R499-R503
40. Kotz C.M., Grace M.K., Briggs J., Levine A.S., and Billington C.J. Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. J Clin Invest 96 (1995) 163-170
41. Quinn J.G., O'Hare E., Levine A.S., and Kim E.M. Evidence for a m-opioid-opioid connection between the paraventricular nucleus and ventral tegmental area in the rat. Brain Res 991 (2003) 206-211
42. Bomberg E.M., Grace M.K., Levine A.S., and Olszewski P.K. Functional interaction between nociceptin/orphanin FQ and a-melanocyte-stimulating hormone in the regulation of feeding. Peptides 27 (2006) 1827-1834
43. Grossman H.C., Hadjimarkou M.M., Silva R.M., Giraudo S.Q., and Bodnar R.J. Interrelationships between m opioid and melanocortin receptors in mediating food intake in rats. Brain Res 991 (2003) 240-244
44. Hagan M.M., Rushing P.A., Benoit S.C., Woods S.C., and Seeley R.J. Opioid receptor involvement in the effect of AgRP-(83-132) on food intake and food selection. Am J Physiol, Regul Integr Comp Physiol 280 3 (2001) R814-821
45. Olszewski P.K., Wirth M.M., Grace M.K., Levine A.S., and Giraudo S.Q. Evidence of interactions between melanocortin and opioid systems in regulation of feeding. NeuroReport 12 8 (2001) 1727-1730
46. Liebowitz S.F., and Hor L. Endorphinergic and α-noradrenergic systems in the paraventricular nucleus: effects on eating behavior. Peptides 3 (1982) 421-428
47. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 3rd ed (1997), Academic Press, San Diego
48. Cowley M.A., Pronchuk N., Fan W., Dinulescu D.M., Colmers W.F., and Cone R.D. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24 (1999) 155-163
49. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., and Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature (1997) 385
50. Kim E.M., Quinn J.G., Levine A.S., and O'Hare E. A bi-directional m-opioid-opioid connection between the nucleus of the accumbens shell and the central nucleus of the amygdala in the rat. Brain Res 1029 (2004) 135-139
51. Levine A.S., Olszewski P.K., Mullett M.A., Pomonis J.D., Grace M.K., Kotz C.M., et al. Intra-amygdalar injection of DAMGO: effects on c-Fos levels in brain sites associated with feeding behavior. Brain Res 1015 (2004) 9-14
52. Rogan M.T., and LeDoux J.E. Emotion: systems, cells, synaptic plasticity. Cell 85 (1996) 469-475
53. Carr K.D., Kutchukhidze N., and Park T.H. Differential effects of m and k opioid antagonists on Fos-like immunoreactivity in extended amygdala. Brain Res 822 (1999) 34-42
54. Park T.H., and Carr K.D. Neuranatomical patterns of Fos-like immunoreactivity induced by a palatable meal and meal-paired environment in saline-and naltrexone-treated rats. Brain Res 805 (1998) 169-180
55. Ward H.G., Nicklous D.M., Aloyo V.J., and Simansky K.J. Mu-opioid receptor cellular function in the nucleus accumbens is essential for hedonically driven eating. Eur J Neurosci 23 (2006) 1605-1613
56. Carr K.D., Park T.H., Zhang Y., and Stone E.A. Neuroanatomical patterns of Fos-like immunoreactivity induced by naltrexone in food-restricted and ad libitum fed rats. Brain Res 779 (1998) 26-32
57. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., and Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8 (1994) 1298-1308
58. Thiele T.E., Van Dijk G., Yagaloff K.A., Fisher S.L., Schwartz M., Burn P., et al. Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. Am J Physiol Regul Integ Comp Physiol (1998) R248-R254
59. Trivedi P., Jiang M., Tamvakopoulos C.C., Shen X., Yu H., Mock S., et al. Exploring the site of anorectic action of peripherally administered synthetic melanocortin peptide MT-II in rats. Brain Res 977 (2003) 221-230